# Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis

> **NCT02402348** · EARLY_PHASE1 · TERMINATED · sponsor: **West Virginia University** · enrollment: 3 (actual)

## Conditions studied

- Cancer of Head and Neck

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02402348
- **Lead sponsor:** West Virginia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Funding not available, PI left institution
- **Last updated:** 2017-02-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02402348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02402348, "Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT02402348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
